PMC:7160442 / 10427-10963 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"107","span":{"begin":149,"end":159},"obj":"Disease"},{"id":"108","span":{"begin":363,"end":371},"obj":"Disease"},{"id":"109","span":{"begin":452,"end":460},"obj":"Disease"}],"attributes":[{"id":"A107","pred":"tao:has_database_id","subj":"107","obj":"MESH:D007239"},{"id":"A108","pred":"tao:has_database_id","subj":"108","obj":"MESH:C000657245"},{"id":"A109","pred":"tao:has_database_id","subj":"109","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"It has taken China around 100 days to start getting back to ‘normal’ and early signals from some countries seem to indicate that the increase of new infections may have slowed down. However, the majority of countries worldwide are just beginning to see a surge in cases and excess all-cause mortality is high in several of the European countries most affected by COVID-19 [21]. While it is yet impossible to predict where we will be 100 days from now, COVID-19 will certainly still be on our agenda and there is no room for complacency."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T6","span":{"begin":52,"end":56},"obj":"Body_part"}],"attributes":[{"id":"A6","pred":"fma_id","subj":"T6","obj":"http://purl.org/sig/ont/fma/fma25056"}],"text":"It has taken China around 100 days to start getting back to ‘normal’ and early signals from some countries seem to indicate that the increase of new infections may have slowed down. However, the majority of countries worldwide are just beginning to see a surge in cases and excess all-cause mortality is high in several of the European countries most affected by COVID-19 [21]. While it is yet impossible to predict where we will be 100 days from now, COVID-19 will certainly still be on our agenda and there is no room for complacency."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T39","span":{"begin":149,"end":159},"obj":"Disease"},{"id":"T40","span":{"begin":363,"end":371},"obj":"Disease"},{"id":"T41","span":{"begin":452,"end":460},"obj":"Disease"}],"attributes":[{"id":"A39","pred":"mondo_id","subj":"T39","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A40","pred":"mondo_id","subj":"T40","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A41","pred":"mondo_id","subj":"T41","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"It has taken China around 100 days to start getting back to ‘normal’ and early signals from some countries seem to indicate that the increase of new infections may have slowed down. However, the majority of countries worldwide are just beginning to see a surge in cases and excess all-cause mortality is high in several of the European countries most affected by COVID-19 [21]. While it is yet impossible to predict where we will be 100 days from now, COVID-19 will certainly still be on our agenda and there is no room for complacency."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T64","span":{"begin":3,"end":6},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T65","span":{"begin":79,"end":86},"obj":"http://purl.obolibrary.org/obo/SO_0000418"},{"id":"T66","span":{"begin":253,"end":254},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"It has taken China around 100 days to start getting back to ‘normal’ and early signals from some countries seem to indicate that the increase of new infections may have slowed down. However, the majority of countries worldwide are just beginning to see a surge in cases and excess all-cause mortality is high in several of the European countries most affected by COVID-19 [21]. While it is yet impossible to predict where we will be 100 days from now, COVID-19 will certainly still be on our agenda and there is no room for complacency."}

{"project":"LitCovid-sentences","denotations":[{"id":"T61","span":{"begin":0,"end":181},"obj":"Sentence"},{"id":"T62","span":{"begin":182,"end":377},"obj":"Sentence"},{"id":"T63","span":{"begin":378,"end":536},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"It has taken China around 100 days to start getting back to ‘normal’ and early signals from some countries seem to indicate that the increase of new infections may have slowed down. However, the majority of countries worldwide are just beginning to see a surge in cases and excess all-cause mortality is high in several of the European countries most affected by COVID-19 [21]. While it is yet impossible to predict where we will be 100 days from now, COVID-19 will certainly still be on our agenda and there is no room for complacency."}